Several studies have demonstrated cross-talk between HER2 and IGF1R [42–44], suggesting that obesity-induced IGF1R signaling may further enhance HER2 activity. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.